Corium Innovations, Inc.
FDA inspection history in Grand Rapids, Michigan, 2017 to 2022
- 3
- Form 483s
Every document, by year
- Form 483
2017: one Form 483; 2019: one Form 483; 2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2017–19Two Form 483s, at Grand Rapids, Michigan.
- 2022One Form 483, at Grand Rapids, Michigan.
- 2022The longest 483 on file: 3 observations over 5 pages at Grand Rapids, Michigan.
Cited most
Across all Corium Innovations observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products2
- 21 CFR 211.160General requirements1
- 21 CFR 211.192Production record review1
- 21 CFR 211.198Complaint files1
- 21 CFR 211.22(d)Responsibilities of quality control unit1
The complete Corium Innovations file.
All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Grand Rapids, Michigan
Three Form 483s · 2017 to 2022 · 7 observations
Latest: Form 483, Nov 18, 2022 →
Documents
3 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-11-18 | 483 Form 483 | Grand Rapids, Michigan | 3 | $99 |
| 2019-09-20 | 483 Form 483 | Grand Rapids, Michigan | 1 | $99 |
| 2017-10-27 | 483 Form 483 | Grand Rapids, Michigan | 3 | $99 |
Investigators on these documents
FEI number 3003693105 · most recent document Nov 18, 2022
About Corium Innovations, Inc.
How many FDA Form 483s has Corium Innovations, Inc. received?
FDA Intel has 3 Form 483s on file for Corium Innovations, Inc.; the most recent is dated Nov 18, 2022.
When was Corium Innovations, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Corium Innovations, Inc. is a Form 483 dated Nov 18, 2022, for the site in Grand Rapids, Michigan.
What did FDA cite at Corium Innovations, Inc.?
The regulations cited most in the observations on file for Corium Innovations, Inc. are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 2 times; 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.192 (Production record review), 1 time.